Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

State Tobacco Excise Taxation, Comprehensive Smoke-free Air Laws, and Tobacco Control Appropriations as Predictors of Smoking Cessation Success in the United States

Dahne, Jennifer PhD; Nahhas, Georges J. PhD, MPH; Wahlquist, Amy E. MS; Cummings, K. Michael PhD, MPH; Carpenter, Matthew J. PhD

Journal of Public Health Management and Practice: November 28, 2018 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/PHH.0000000000000865
Research Brief Report: PDF Only

The purpose of the present study was (1) to examine demographic differences between smokers who successfully quit (n = 1809), who relapsed (n = 6548), and who did not attempt to quit (n = 11 102) within the last year, and (2) to examine state-level tobacco policies/programs as predictors of quit success. Data were utilized from the 2014-2015 Tobacco Use Supplement to the Current Population Survey, which were paired with 2014 data on taxation, appropriations, and smoke-free air laws. As compared with smokers who relapsed, those who successfully quit were more likely to be white, married, more highly educated, of higher income, and heavier smokers. Compared with those who did not attempt to quit, those who attempted to quit, regardless of success, were younger and more likely to be Hispanic. State comprehensive smoke-free air laws and tobacco excise taxation significantly predicted quit success. Thus, expansions of these policies should be considered to promote successful quitting.

Department of Psychiatry and Behavioral Sciences (Drs Dahne, Nahhas, Cummings, and Carpenter), Hollings Cancer Center (Drs Dahne, Cummings, and Carpenter and Ms Wahlquist), and Department of Public Health Sciences (Ms Wahlquist and Drs Cummings and Carpenter), Medical University of South Carolina, Charleston, South Carolina.

Correspondence: Jennifer Dahne, PhD, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President St, MSC 861, Charleston, SC 29425 (

This work was supported by the National Institutes of Health (K23 DA045766 to J.D.). The sponsor had no role in the design and conduct of the study or in the preparation, review, or approval of the manuscript.

The authors thank Anne Hartman for her feedback on an earlier version of the manuscript and for help with understanding the TUS-CPS data set.

KMC has received grant funding from Pfizer, Inc to study the impact of a hospital-based tobacco cessation intervention and has also served as an expert witness in litigation filed against the tobacco industry. The remaining authors declare no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.